Zentalis Pharmaceuticals Inc (ZNTL)
NASDAQ
Fin d'année 31 Décembre 2023 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -102.771 | -71.082 | -52.023 | -38.71 | -47.656 | -53.564 |
Return on Equity (%) | -130.422 | 222.86 | -90.615 | -45.489 | -59.312 | -67.061 |
Return on Invested Capital (%) | -138.553 | -97.641 | -60.472 | -65.021 | -67.948 | -76.233 |
Operating Margin (%) | -167342.857 | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | -150478.571 | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | 1.372 | 3.378 | 5.572 | 5.815 | 5.675 | 4.967 |
Earnings Per Share | -1.462 | -2.76 | -2.046 | -2.559 | -3.123 | -3.347 |
Cash Per Share | 1.745 | 4.065 | 0.954 | 0.963 | 0.568 | 0.321 |
Working Capital Per Share | 1.42 | 3.264 | 5.496 | 4.946 | 5.213 | 4.895 |
Operating Profit Per Share | 0.001 | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | -1.626 | -2.802 | -2.051 | -2.682 | -3.133 | -3.355 |
EBITDA Per Share | -1.626 | -2.802 | -2.051 | -2.682 | -3.133 | -3.355 |
Free Cash Flow Per Share | -1.45 | -2.746 | -2.036 | -2.469 | -3.108 | -3.356 |
Fin d'année 31 Décembre 2023 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | N/A | N/A | 41,04M | 45,49M | 59,28M | N/A |
Fin d'année 31 Décembre 2023 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |||
Actions en circulation | 59,28M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | 25.106 | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | 24.822 | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 159,63M |
Ratio cours/bénéfice | -0,55 |
Ratio prix/ventes | 0 |
Ratio prix/liquidités | 5,77 |
Ratio prix/valeur comptable | 0,37 |
Rendement de dividende | - |
Actions en circulation | 71,27M |
Volume moyen (1 semaine) | 2,37M |
Volume moyen (1 mois) | 1,67M |
Variation sur 52 semaines | -82,52% |
Plus haut sur 52 semaines | 18,07 |
Plus bas sur 52 semaines | 2,16 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales